Delivery Order SPE2DB20D1100-SPE2DB24FD2C0

Award Date 8/9/24
Potential Completion Date 8/12/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,187.36 firm fixed-price delivery order is for the supply of OPZELURA 1.5% cream, a pharmaceutical product, with a period of performance through January 6, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $1,296.04, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract involves the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, to support the federal government's medical supply needs. This award is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $12,450.10 for the supply of OPZELURA 1.5% CREAM 60GM. The contract is issued by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of prescription medications, medical supplies, and other healthcare products to support various government agencies and...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of OPZELURA 1.5% CREAM 60GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $5,729.45 firm fixed-price delivery order contract has a ceiling value and an ultimate completion date of July 30, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several indefinite delivery contracts (IDCs) with the DLA and other federal agencies to...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,757.38 firm fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram sizes. The contract has an ultimate completion date of March 26, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,250.23, is for the delivery of OPZELURA 1.5% Cream in 60 gram tubes. The award has a completion date of November 7, 2024 and is a firm fixed-price contract. The contract is not designated with a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,412.31 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% Cream, a medical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product OPZELURA 1.5% Cream in 60 gram quantities. The $1,342.69 firm fixed-price delivery order was issued by the Defense agency Medical Supply Chain (DLA Troop Support Medical) and has an ultimate completion date of April 17, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,301.20 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% Cream in 60-gram tubes. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This federal contract award, valued at $1,845.78, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is a Delivery Order for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with an ultimate completion date of October 10, 2024. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD2C0
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $3,450.57 firm-fixed-price delivery order is for the supply of OPZELURA 1.5% CREAM 60GM, a prescription medication. This award is not associated with a set-aside program. Amerisourcebergen has been awarded numerous federal contracts by various defense and civilian agencies to provide a wide range of pharmaceutical products and medical supplies, including specialty medications, generic drugs, and critical care materials. The company holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999 through 2025, and the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through 2024, to deliver essential medical commodities in support of military treatment programs, veterans' healthcare, and other federal beneficiaries.

Generated 11/8/24, 9:11 AM